Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective. Biomol Biomed. 2022;22(5):699-706. doi:10.17305/bjbms.2021.7326